Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CASI Pharmaceuticals (CASI) Debt Ratio (2021 - 2024)

Historic Debt Ratio for Pharmaceuticals (CASI) over the last 4 years, with Q4 2024 value amounting to 0.34.

  • Pharmaceuticals' Debt Ratio fell 9986.36% to 0.34 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.34, marking a year-over-year decrease of 9986.36%. This contributed to the annual value of 0.34 for FY2024, which is 9986.36% down from last year.
  • Per Pharmaceuticals' latest filing, its Debt Ratio stood at 0.34 for Q4 2024, which was down 9986.36% from 360145.11 recorded in Q2 2024.
  • Over the past 5 years, Pharmaceuticals' Debt Ratio peaked at 360145.11 during Q2 2024, and registered a low of 0.1 during Q4 2021.
  • Its 4-year average for Debt Ratio is 60066.17, with a median of 0.33 in 2024.
  • As far as peak fluctuations go, Pharmaceuticals' Debt Ratio surged by 20426703.33% in 2023, and later tumbled by 9986.36% in 2024.
  • Over the past 4 years, Pharmaceuticals' Debt Ratio (Quarter) stood at 0.1 in 2021, then increased by 28.5% to 0.12 in 2022, then surged by 204267.03% to 251.04 in 2023, then crashed by 99.86% to 0.34 in 2024.
  • Its last three reported values are 0.34 in Q4 2024, 360145.11 for Q2 2024, and 0.32 during Q1 2024.